Merck & Co., Inc.'s Frazier Eyes Partnerships, Acquisitions

Merck CEO Ken Frazier isn’t ruling out the possibility of making acquisitions in 2012 as a way of bolstering the company’s pipeline of prospective medicines. “My goal is to augment the pipeline. The way to augment is to find those assets that we can acquire,’‘ Frazier said during a webcast of a Goldman Sachs healthcare event in New York City. “Typically, for Merck, the sweet spot has been (to acquire them) earlier rather than later.’‘ “Unquestionably,’‘ Frazier said, “you should expect more deal activity and more product-driven business development.’‘